Skip to content

Surgery for Locally Advanced Colon Cancer: is it Worth it? A Multicenter Retrospective Analysis.

Surgery for Locally Advanced Colon Cancer: is it Worth it? A Multicenter Retrospective Analysis. (LACC Trial)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04646772
Acronym
LACC
Enrollment
100
Registered
2020-11-30
Start date
2021-01-01
Completion date
2021-06-30
Last updated
2020-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant Neoplasm of Large Intestine TNM Staging Primary Tumor (T) T4

Brief summary

The aim of the present study is to assess the post-operative outcomes (morbidity and mortality) in relation to preoperative data and the oncological outcomes (overall and disease-free survival) in patients with a locally advanced colon cancer (LACC) with the necessity of a multivisceral resection (MVR).

Detailed description

All patients that meet the inclusion criteria will be registered in a retrospective database from 2014 to 2019 (5 years) Data will be reported for every patients with colon cancer to have had either a resection of another organ or structure in addition to resection of the primary tumor, or to have had a T4 (a or b) tumour on postoperative histopathology. Data included are patient demographics, ASA score, tumor localization, preoperative imaging, neoadjuvant treatments, type of bowel resection and adjacent organs resected, tecnique (laparoscopic/laparotomic), postoperative complications and 30-day mortality, histopathology data including TNM scoring, completeness of surgical procedure (R0 to R2) and infiltration of tumor cells in resected tissues, adjuvant oncological treatments, and long term follow-up data on local and distant recurrence and survival.

Interventions

Multivisceral resection for locally advanced colon cancer.

Sponsors

Santo Spirito Hospital, Italy
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* \> 18 aa * Patients with a locally advanced colon cancer (LACC) with the necessity of a multivisceral resection (MVR).

Exclusion criteria

* Stage IV * Rectal cancer * Emergency surgery (\<48 hours from admission) * ASA \> III

Design outcomes

Primary

MeasureTime frameDescription
Postoperative morbidity30 daysI evaluate peri and post-operative surgical (e.g. intraabdominal collection, fistula, anastomotic leak) and medical (e.g. pneumoniae, deep vein thrombosis) complications
Postoperative mortality30 daysI evaluate in-hospital and 30-day mortality correlate to the intervention

Secondary

MeasureTime frameDescription
Overall Survival5 yearsThe length of time from the intervention that patients diagnosed with a T4 colon cancer are still alive.
Disease Free Survival5 yearsThe measure of time after treatment during which no sign of recurrence (local or metastatic) is found.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026